Lagane Bernard, Ballet Sébastien, Planchenault Thierry, Balabanian Karl, Le Poul Emmanuel, Blanpain Cédric, Percherancier Yann, Staropoli Isabelle, Vassart Gilbert, Oppermann Martin, Parmentier Marc, Bachelerie Françoise
Institut Pasteur, Unité d'Immunologie Virale, 28 rue du Dr Roux, 75015 Paris, France.
Mol Pharmacol. 2005 Jun;67(6):1966-76. doi: 10.1124/mol.104.009779. Epub 2005 Mar 10.
CC chemokine receptor 5 (CCR5) is a G protein-coupled receptor that governs migration of leukocytes and serves as a coreceptor for the R5 tropic strains of human immunodeficiency virus (HIV). CCR5-mediated signaling in response to CC chemokines relies on G protein activation. Desensitization, which rapidly turns off G protein-dependent signaling, involves phosphorylation of CCR5 that promotes interaction of the receptor with beta-arrestins for endocytosis. Whether coupling to G proteins, desensitization, and endocytosis of CCR5 require the same structural determinants remains a matter of investigation. Here, we show that CCR5 displayed agonist-independent coupling to G proteins. This constitutive activity of the receptor was abrogated by TAK779 (N,N-dimethyl-N-[4-[[[2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-yl]carbonyl]amino]benzyl]tetrahydro-2H-pyran-4-aminium chloride), a nonpeptidic CCR5 ligand that inhibits HIV infection and was found to depend on the integrity of the Asp-Arg-Tyr (DRY) motif. Changing Arg-126 by the neutral residue Asn (R126N-CCR5 mutant) abolished CCR5-mediated activation of G proteins, either constitutively or in response to agonists. In contrast, R126N-CCR5 not only retained agonist-promoted phosphorylation and beta-arrestin-dependent endocytosis but also displayed a higher basal phosphorylation than wild-type CCR5. Expression of beta-arrestin in R126N-CCR5-expressing cells resulted in receptor down-regulation, thereby suggesting that R126N-CCR5 spontaneously interacts with beta-arrestins. However, although expression of beta-arrestin favored wild-type CCR5-mediated chemotaxis, it failed to promote migration of cells expressing R126N-CCR5. Overall, these data indicate that structural requirements for CCR5-mediated activation of G proteins, albeit not involved in receptor desensitization and internalization, are needed for beta-arrestin-mediated chemotaxis. These results have implications for how distinct biological responses of CCR5 might rely on a different set of receptor conformations.
C-C趋化因子受体5(CCR5)是一种G蛋白偶联受体,它调控白细胞的迁移,并作为人类免疫缺陷病毒(HIV)R5嗜性毒株的共受体。CCR5介导的对C-C趋化因子的信号响应依赖于G蛋白激活。脱敏作用可迅速关闭G蛋白依赖性信号传导,它涉及CCR5的磷酸化,这种磷酸化促进受体与β-抑制蛋白相互作用以实现内吞作用。CCR5与G蛋白的偶联、脱敏作用以及内吞作用是否需要相同的结构决定因素仍是一个有待研究的问题。在此,我们表明CCR5表现出与G蛋白的非激动剂依赖性偶联。受体的这种组成性活性被TAK779(N,N-二甲基-N-[4-[[[2-(4-甲基苯基)-6,7-二氢-5H-苯并环庚烯-8-基]羰基]氨基]苄基]四氢-2H-吡喃-4-氯化铵)消除,TAK779是一种非肽类CCR5配体,可抑制HIV感染,且发现其依赖于天冬氨酸-精氨酸-酪氨酸(DRY)基序的完整性。将精氨酸126替换为中性残基天冬酰胺(R126N-CCR5突变体)消除了CCR5介导的G蛋白激活,无论是组成性激活还是对激动剂的响应激活。相比之下,R126N-CCR5不仅保留了激动剂促进的磷酸化和β-抑制蛋白依赖性内吞作用,而且其基础磷酸化水平高于野生型CCR5。在表达R126N-CCR5的细胞中β-抑制蛋白的表达导致受体下调,从而表明R126N-CCR5可自发地与β-抑制蛋白相互作用。然而,尽管β-抑制蛋白的表达有利于野生型CCR5介导的趋化作用,但它未能促进表达R126N-CCR5的细胞迁移。总体而言,这些数据表明CCR5介导的G蛋白激活的结构要求虽然不参与受体脱敏和内化,但却是β-抑制蛋白介导的趋化作用所必需的。这些结果对于CCR5不同的生物学反应如何可能依赖于一组不同的受体构象具有启示意义。